Financial Statements

Aptevo Therapeutics Inc. (APVO)

$ 17.9
-0.261 (-1.43%)
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in millions

Retained Earning Schedule

Year 2020 2019 2018 2017 2016 2015 2014
Retained Earnings (Previous Year) -168-127-74-81-232-173-
Net Income -18-40-547-112-59-51
Stock Dividends 186---264--122
Dividend Paid -------
Retained Earnings --168-127-74-81-232-173

PPE Schedule

Year 2020 2019 2018 2017 2016 2015 2014
Gross PPE 856643-
Annual Depreciation -5301434
Capital Expenditure -0-0-1-1-3-2-1
Net PPE 3856643

Intangible and Goodwill Schedule

Year 2020 2019 2018 2017 2016 2015 2014
Intangible and Goodwill (Previous Year) -757315654
New Purchases ---45-100-17--
Intangible and Goodwill 757315654-

Aptevo Therapeutics Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Aptevo Therapeutics Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.